261 related articles for article (PubMed ID: 7851494)
1. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2.
Schepp W; Schmidtler J; Riedel T; Dehne K; Schusdziarra V; Holst JJ; Eng J; Raufman JP; Classen M
Eur J Pharmacol; 1994 Oct; 269(2):183-91. PubMed ID: 7851494
[TBL] [Abstract][Full Text] [Related]
2. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
4. GLP-1-(7-36) amide, -(1-37), and -(1-36) amide: potent cAMP-dependent stimuli of rat parietal cell function.
Schmidtler J; Schepp W; Janczewska I; Weigert N; Fürlinger C; Schusdziarra V; Classen M
Am J Physiol; 1991 Jun; 260(6 Pt 1):G940-50. PubMed ID: 1711782
[TBL] [Abstract][Full Text] [Related]
5. Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.
Schmidtler J; Dehne K; Allescher HD; Schusdziarra V; Classen M; Holst JJ; Polack A; Schepp W
Am J Physiol; 1994 Sep; 267(3 Pt 1):G423-32. PubMed ID: 7943240
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function.
Gros L; Hollande F; Thorens B; Kervran A; Bataille D
Eur J Pharmacol; 1995 Feb; 288(3):319-27. PubMed ID: 7774676
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of rat parietal cell function by histamine and GLP-1-(7-36) amide is mediated by Gs alpha.
Schmidtler J; Dehne K; Offermanns S; Rosenthal W; Classen M; Schepp W
Am J Physiol; 1994 May; 266(5 Pt 1):G775-82. PubMed ID: 8203524
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin-sensitive inhibition of glucagon-like peptide 1-stimulated acid production by epidermal growth factor and transforming growth factor alpha in rat parietal cells.
Schmidtler J; Dehne K; Schusdziarra V; Classen M; Schepp W
Eur J Pharmacol; 1993 Jun; 246(1):59-66. PubMed ID: 8394819
[TBL] [Abstract][Full Text] [Related]
9. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
Montrose-Rafizadeh C; Yang H; Rodgers BD; Beday A; Pritchette LA; Eng J
J Biol Chem; 1997 Aug; 272(34):21201-6. PubMed ID: 9261127
[TBL] [Abstract][Full Text] [Related]
10. Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.
Raufman JP; Singh L; Singh G; Eng J
J Biol Chem; 1992 Oct; 267(30):21432-7. PubMed ID: 1328231
[TBL] [Abstract][Full Text] [Related]
11. Pertussis toxin-sensitive and pertussis toxin-insensitive inhibition of parietal cell response to GLP-1 and histamine.
Schepp W; Schmidtler J; Dehne K; Schusdziarra V; Classen M
Am J Physiol; 1992 Apr; 262(4 Pt 1):G660-8. PubMed ID: 1348905
[TBL] [Abstract][Full Text] [Related]
12. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
Kolligs F; Fehmann HC; Göke R; Göke B
Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
[TBL] [Abstract][Full Text] [Related]
13. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39).
Fehmann HC; Jiang J; Schweinfurth J; Wheeler MB; Boyd AE; Göke B
Peptides; 1994; 15(3):453-6. PubMed ID: 7937318
[TBL] [Abstract][Full Text] [Related]
14. Rat gastric somatostatin and gastrin release: interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide.
Eissele R; Bothe-Sandfort E; Göke B; Eng J; Arnold R; Koop H
Life Sci; 1994; 55(8):629-34. PubMed ID: 7913983
[TBL] [Abstract][Full Text] [Related]
15. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor.
Thorens B; Porret A; Bühler L; Deng SP; Morel P; Widmann C
Diabetes; 1993 Nov; 42(11):1678-82. PubMed ID: 8405712
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
17. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
[TBL] [Abstract][Full Text] [Related]
18. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
[TBL] [Abstract][Full Text] [Related]
20. Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary.
Göke R; Larsen PJ; Mikkelsen JD; Sheikh SP
Neuroendocrinology; 1995 Aug; 62(2):130-4. PubMed ID: 8584112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
